Clinical trial
Detection and Prevalence of Human Papillomavirus (HPV) in Seminal Plasma and/or on Sperm in Men Undergoing Treatment With IVF/ICSI in Southwestern Sweden: a Prospective Study.
NCT06161727 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection and Prevalence of Human Papillomavirus (HPV) in Seminal Plasma and/or on Sperm in Men Undergoing Treatment With IVF/ICSI in Southwestern Sweden: a Prospective Study.
- Lead sponsor
- Vastra Gotaland Region
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2023
- Completion date
- March 28, 2024
- Enrollment
- 260 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human papilloma virus, infertility, male